Keros Therapeutics (KROS) Interest Coverage Ratio (2019 - 2022)
Keros Therapeutics (KROS) reported Interest Coverage Ratio of 24126.0 for Q1 2022, down 53.0% on a YoY basis from 51327.97 in Q1 2021, and down 395.81% quarter-over-quarter from 4866.0 in Q4 2021.
Keros Therapeutics (KROS) Interest Coverage Ratio (2019 - 2022) Analysis & Trends
Keros Therapeutics has reported Interest Coverage Ratio for 4 years, with the latest figure at 24126.0 in Q1 2022.
- For the quarter ending Q1 2022, Interest Coverage Ratio fell 53.0% year-over-year to 24126.0; the trailing twelve-month figure through Dec 2022 stood at 114790.0 (down 714.5% YoY), and the FY2022 full-year result was 114790.0, down 714.5% from the prior year.
- Interest Coverage Ratio for Q1 2022 stood at 24126.0, down from 4866.0 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 775.33 in Q3 2019, with the low at 24126.0 in Q1 2022.
- Historically, Interest Coverage Ratio has averaged 9954.99 across 4 years, with a median of 8444.0 in 2020.
- Annual changes were most pronounced in 2020 — Interest Coverage Ratio plunged 723.39% — and 2021, when it surged 63.39%.
- Keros Therapeutics' Interest Coverage Ratio stood at 775.33 in 2019, then slumped by 1614.23% to 13291.0 in 2020, then surged by 63.39% to 4866.0 in 2021, then plunged by 395.81% to 24126.0 in 2022.
- The last three Interest Coverage Ratio figures came in at 24126.0 (Q1 2022), 4866.0 (Q4 2021), and 20197.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Keros Therapeutics | 399.01 Mn | 111.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -24,126.00 |
| Dec 31, 2021 | -4,866.00 |
| Sep 30, 2021 | -20,197.00 |
| Jun 30, 2021 | -15,541.00 |
| Mar 31, 2021 | -15,769.00 |
| Dec 31, 2020 | -13,291.00 |
| Sep 30, 2020 | -5,974.00 |
| Jun 30, 2020 | -10,914.00 |
| Mar 31, 2020 | -5,252.00 |
| Sep 30, 2019 | -775.33 |
| Jun 30, 2019 | -1,325.50 |
| Mar 31, 2019 | -1,429.00 |